Switzerland’s government, including Economy Minister Guy Parmelin and Interior Minister Elisabeth Baume-Schneider, have reached out with Roche (RHHBY) and Novartis (NVS) to discuss the tariffs imposed by the U.S. on the country, Bloomberg reports, citing comments made by a spokesperson. While pharmaceuticals are currently exempt from the tariffs, that may soon change, with the president warning of possible measures on the sector in the next weeks.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Trump, pharma industry discuss increasing medicine spending abroad, Reuters says
- Roche downgraded to Underweight from Equal Weight at Morgan Stanley
- Roche Holding AG Faces Growth Challenges Amidst Competition and Regulatory Risks, Downgraded to Underweight
- Trump Weekly: President says raising tariffs on India ‘substantially’
- Trump says separate tariff announcements coming for semi chips, pharmaceuticals